Download | < Back |
09 Jan 2017 | |
Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the Form 483 observations of the US-FDA within the time permitted. | |
View all announcements for DIVI'S LABORATORIES LTD. | Source: BSE India |